A Mom Said Infant Formula Killed Her Baby. The Manufacturer Didn’t Tell the FDA.
In September 2016, a distraught mother sent infant formula maker Mead Johnson a message: “REMOVE…
A Mom Said Infant Formula Killed Her Baby. The Manufacturer Didn’t Tell the FDA.
In September 2016, a distraught mother sent infant formula maker Mead Johnson a message: “REMOVE ME FROM YOUR LIST!!!! DO NOT EMAIL OR MAIL ME ANY MORE! “It is because of your animal based pre-term artificial baby food crap that you peddle to hospital NICU’s that my son is dead from NEC.” The mother was…
New Disease Threats Follow Trump Administration’s Health Program Cuts
As beachgoers flock to water during the busy July Fourth weekend, danger could be lurking in some areas. Researchers this spring discovered flesh-eating bacteria in water in several coastal locations across New York’s Long Island, and town officials in the Hamptons vacation destination posted an alert about the findings. Eight people in Florida have been…
HealthQ Special: Caregiving in the Sandwich Generation
We’re expecting our first baby boy in end of August. And when I think about what it’s going to feel like to take care of my wife and my new son and my mom, it’s a bit overwhelming. William Morrison, from Nashville, Tennessee If you are taking care of a child and you have a…
FDA Clears First Neurostimulation Device for PTSD
Neurovalens’ Modius Spero has become the first FDA-approved neuromodulation device for treating PTSD symptoms. Veterans are set to gain access through the VA this summer. The post FDA Clears First Neurostimulation Device for PTSD appeared first on MedCity News.
Orca Bio Cell Therapy Gets Landmark FDA Nod for New Kind of Living Medicine
FDA approval of Orca Bio’s Tregzi makes it the first cell therapy based on regulatory T cells, or Tregs. Clinical trial results showed reduced risk of graft-versus-host disease, a common complication of the allogeneic stem cell transplants that are a standard treatment for certain blood cancers. The post Orca Bio Cell Therapy Gets Landmark FDA…
How did Washington State’s PDAB select drugs?
Many policymakers are looking for ways to reduce drug spending. Federal policymakers are not the only ones looking at the issue. In recent years, state Prescription Drug Affordability Boards (PDABs) have formed to reduce drug prices. A paper by Barthold et al. (2026) describes the what PDABs are: As of April 2025, 12 states had…
Evernorth Invests $100M for AI Specialty Pharmacy Program
Evernorth is investing $100 million through 2028 in Pharmacy Forward, an AI-powered program aimed at improving specialty pharmacy operations and patient care. The post Evernorth Invests $100M for AI Specialty Pharmacy Program appeared first on MedCity News.
Medical Frailty and Medicaid Work Requirements: Challenges for People with HIV
This analysis examines Medicaid work requirements and the implementation of medical frailty exclusions for people with HIV in light of CMS’s implementing regulation.
How Has Projected Medicaid Spending and Enrollment Changed Since Passage of the 2025 Reconciliation Law?
CBO’s latest projections of Medicaid spending and enrollment from February 2026 show how enrollment and spending are expected to change over the next decade, accounting for the historic policy changes and their expected reductions in future federal Medicaid spending, as well as other economic and technical changes. This policy watch compares CBO’s February 2026 projections…
Medicare Will Spend More Than $13 Billion on the Medicare Advantage Quality Bonus Program in 2026
The Medicare program will spend at least $13 billion on the Medicare Advantage quality bonus program in 2026, as 68% of Medicare Advantage enrollees are in a plan that qualifies for higher payments under the program.
